Management of cirrhotic ascites

Area of Science:

• Gastroenterology
• Nephrology
• Internal Medicine

Background:

• Cirrhotic ascites is a common complication of advanced liver disease.
• Pathogenesis theories include underfill and overflow mechanisms, likely acting as a continuum.
• Ascitic fluid analysis is crucial to rule out other causes like malignancy or infection.

Purpose of the Study:

• To review the pathogenesis and diagnosis of cirrhotic ascites.
• To describe treatment options, emphasizing pharmacologic management.
• To highlight the role of diuretics and monitoring.

Main Methods:

• Review of existing literature on cirrhotic ascites pathogenesis and treatment.
• Focus on pharmacologic interventions, particularly diuretics.
• Discussion of diagnostic considerations and monitoring parameters.

Main Results:

• Ascites formation involves a continuum of overflow and underfill mechanisms.
• Spironolactone is the preferred initial pharmacologic agent for nonazotemic patients.
• Combination diuretic therapy or paracentesis with albumin may be used for refractory cases.

Conclusions:

• Conservative management with sodium restriction and bed rest is the initial approach.
• Spironolactone is a first-line pharmacologic treatment for cirrhotic ascites.
• Close monitoring of electrolytes and renal function is essential during diuretic therapy.